Arunjyoti Bio Ventures has extended the issue closing date from 08 April 2024 to 12 April 2024 in order to provide an opportunity to shareholders to exercise their rights in the rights issue. Powered by Capital Market - Live News

Net loss of Arunjyoti Bio Ventures reported to Rs 0.28 crore in the quarter ended December 2023 as against net profit of Rs 0.03 crore during the previous quarter ended December 2022. Sales rose 1106.25% to Rs 5.79 crore in the quarter ended December 2023 as against Rs 0.48 crore during the previous quarter ended December 2022. ParticularsQuarter Ended�Dec. 2023Dec. 2022% Var. Sales5.790.48 1106 OPM %31.438.33 - PBDT1.110.04 2675 PBT0.440.04 1000 NP-0.280.03 PL Powered by Capital Market - Live News

Arunjyoti Bio Ventures will hold a meeting of the Board of Directors of the Company on 10 February 2024. The meeting would commence at 2.00 pm.Powered by Capital Market - Live News

Arunjyoti Bio Ventures announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 27 November 2023 .Powered by Capital Market - Live News

Net loss of Arunjyoti Bio Ventures reported to Rs 1.37 crore in the quarter ended September 2023 as against net profit of Rs 0.07 crore during the previous quarter ended September 2022. Sales reported to Rs 3.14 crore in the quarter ended September 2023. There were no Sales reported during the previous quarter ended September 2022. ParticularsQuarter Ended�Sep. 2023Sep. 2022% Var. Sales3.140 0 OPM %-10.830 - PBDT-0.840.08 PL PBT-1.380.08 PL NP-1.370.07 PL Powered by Capital Market - Live News